Clinical Trial: Tolerability, Safety, and Efficacy of Tedizolid as Oral Treatment for Bone and Joint Infections

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Tolerability, Safety, and Efficacy of Tedizolid as Oral Treatment for Bone and Joint Infections

Brief Summary: The problem of interest is that doctors are looking for new antibiotic treatments for bone and joint infections. Treatment for bone and joint infection is not standardized, which allows a wide range of antibiotic therapy to potentially be given. A type of bacteria called S. aureus is the most common cause of bone and joint infection. Methicillin resistant S. aureus (MRSA) is a type of bacteria that is not killed by some antibiotics, and it is increasingly common in U.S. and non-U.S. medical centers. This problem will be studied by investigating whether an antibiotic called tedizolid is tolerable, safe and effective to treat bone and joint infections.